Longhurst, H.; Cicardi, M.; Craig, T. et al.
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 InhibitorNEW ENGLAND JOURNAL OF MEDICINE. Bd. 376. H. 12. 2017 S. 1131-1140
Behling, J.; Wilden, S.; Tsimpaki, T. et al.
Primary nodal Kaposi's Sarcoma in the Sonography impacted as Lymph Node Metastases of a malignant TumorJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 15. 2017 S. 77-77
Heppt, M.; Heinzerling, L.; Kaehler, K. et al.
Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibitionJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 15. 2017 S. 14-14
Heppt, Markus V.; Heinzerling, Lucie; Kaehler, Katharina C. et al.
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibitionEUROPEAN JOURNAL OF CANCER. Bd. 82. 2017 S. 56-65
Heppt, Markus V.; Roesch, Alexander; Weide, Benjamin et al.
Prognostic factors and treatment outcomes in 444 patients with mucosal melanomaEUROPEAN JOURNAL OF CANCER. Bd. 81. 2017 S. 36-44
Butsch, Florian; Greger, Dania; Butsch, Christina et al.
Prognostic value of Hutchinson's sign for ocular involvement in herpes zoster ophthalmicusJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 15. H. 5. 2017 S. 563-564
Settanni, Giovanni; Zhou, Jiajia; Suo, Tongchuan et al.
Protein corona composition of poly(ethylene glycol)- and poly(phosphoester)-coated nanoparticles correlates strongly with the amino acid composition of the protein surfaceNANOSCALE. Bd. 9. H. 6. 2017 S. 2138-2144
Gogas, H.; Dummer, R.; Ascierto, P. A. et al.
Quality-of-life (QoL) in COLUMBUS part 1: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus vemurafenib (VEM) or ENCO in braf-mutant melanomaANNALS OF ONCOLOGY. Bd. 28. 2017
Berking, Carola; Ascierto, Paolo A.; Gogas, Helen J. et al.
Quality-of-Life (QoL) in COLUMBUS Part 1: A Phase 3 Trial of Encorafenib (ENCO) Plus Binimetinib (BINI) Versus Vemurafenib (VEM) or ENCO in BRAF-Mutant MelanomaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 15. 2017 S. 45-45
Schultheis, M.; Geppert, C.; Weustenfeld, C. et al.
Rapid Improvement of tumor-related Renal Insufficiency based on BRAF-/MEK-Inhibitor TherapyJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 15. 2017 S. 51-51